Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Different signalling in infarcted and non-infarcted areas of rat failing hearts: A role of necroptosis and inflammation

M. Lichý, A. Szobi, J. Hrdlička, C. Horváth, V. Kormanová, T. Rajtík, J. Neckář, F. Kolář, A. Adameová,

. 2019 ; 23 (9) : 6429-6441. [pub] 20190721

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc20025696

Grantová podpora
NV15-27735A MZ0 CEP - Centrální evidence projektů

Necroptosis has been recognized in heart failure (HF). In this study, we investigated detailed necroptotic signalling in infarcted and non-infarcted areas separately and its mechanistic link with main features of HF. Post-infarction HF in rats was induced by left coronary occlusion (60 minutes) followed by 42-day reperfusion. Heart function was assessed echocardiographically. Molecular signalling and proposed mechanisms (oxidative stress, collagen deposition and inflammation) were investigated in whole hearts and in subcellular fractions when appropriate. In post-infarction failing hearts, TNF and pSer229-RIP3 levels were comparably increased in both infarcted and non-infarcted areas. Its cytotoxic downstream molecule p-MLKL, indicating necroptosis execution, was detected in infarcted area. In non-infarcted area, despite increased pSer229-RIP3, p-MLKL was present in neither whole cells nor the cell membrane known to be associated with necroptosis execution. Likewise, increased membrane lipoperoxidation and NOX2 levels unlikely promoted pro-necroptotic environment in non-infarcted area. Collagen deposition and the inflammatory csp-1-IL-1β axis were active in both areas of failing hearts, while being more pronounced in infarcted tissue. Although apoptotic proteins were differently expressed in infarcted and non-infarcted tissue, apoptosis was found to play an insignificant role. p-MLKL-driven necroptosis and inflammation while inflammation only (without necroptotic cell death) seem to underlie fibrotic healing and progressive injury in infarcted and non-infarcted areas of failing hearts, respectively. Upregulation of pSer229-RIP3 in both HF areas suggests that this kinase, associated with both necroptosis and inflammation, is likely to play a dual role in HF progression.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20025696
003      
CZ-PrNML
005      
20201222154038.0
007      
ta
008      
201125s2019 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1111/jcmm.14536 $2 doi
035    __
$a (PubMed)31328381
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Lichý, Martin $u Faculty of Pharmacy, Department of Pharmacology and Toxicology, Comenius University in Bratislava, Bratislava, Slovak Republic.
245    10
$a Different signalling in infarcted and non-infarcted areas of rat failing hearts: A role of necroptosis and inflammation / $c M. Lichý, A. Szobi, J. Hrdlička, C. Horváth, V. Kormanová, T. Rajtík, J. Neckář, F. Kolář, A. Adameová,
520    9_
$a Necroptosis has been recognized in heart failure (HF). In this study, we investigated detailed necroptotic signalling in infarcted and non-infarcted areas separately and its mechanistic link with main features of HF. Post-infarction HF in rats was induced by left coronary occlusion (60 minutes) followed by 42-day reperfusion. Heart function was assessed echocardiographically. Molecular signalling and proposed mechanisms (oxidative stress, collagen deposition and inflammation) were investigated in whole hearts and in subcellular fractions when appropriate. In post-infarction failing hearts, TNF and pSer229-RIP3 levels were comparably increased in both infarcted and non-infarcted areas. Its cytotoxic downstream molecule p-MLKL, indicating necroptosis execution, was detected in infarcted area. In non-infarcted area, despite increased pSer229-RIP3, p-MLKL was present in neither whole cells nor the cell membrane known to be associated with necroptosis execution. Likewise, increased membrane lipoperoxidation and NOX2 levels unlikely promoted pro-necroptotic environment in non-infarcted area. Collagen deposition and the inflammatory csp-1-IL-1β axis were active in both areas of failing hearts, while being more pronounced in infarcted tissue. Although apoptotic proteins were differently expressed in infarcted and non-infarcted tissue, apoptosis was found to play an insignificant role. p-MLKL-driven necroptosis and inflammation while inflammation only (without necroptotic cell death) seem to underlie fibrotic healing and progressive injury in infarcted and non-infarcted areas of failing hearts, respectively. Upregulation of pSer229-RIP3 in both HF areas suggests that this kinase, associated with both necroptosis and inflammation, is likely to play a dual role in HF progression.
650    _2
$a zvířata $7 D000818
650    _2
$a apoptóza $x fyziologie $7 D017209
650    _2
$a buněčná smrt $x fyziologie $7 D016923
650    _2
$a srdeční selhání $x metabolismus $7 D006333
650    _2
$a zánět $x metabolismus $7 D007249
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a infarkt myokardu $x metabolismus $7 D009203
650    _2
$a kardiomyocyty $x metabolismus $7 D032383
650    _2
$a nekroptóza $x fyziologie $7 D000079302
650    _2
$a nekróza $x metabolismus $7 D009336
650    _2
$a oxidační stres $x fyziologie $7 D018384
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani Sprague-Dawley $7 D017207
650    _2
$a serin-threoninkinasy interagující s receptory $x metabolismus $7 D053422
650    _2
$a signální transdukce $x fyziologie $7 D015398
650    _2
$a upregulace $x fyziologie $7 D015854
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Szobi, Adrián $u Faculty of Pharmacy, Department of Pharmacology and Toxicology, Comenius University in Bratislava, Bratislava, Slovak Republic.
700    1_
$a Hrdlička, Jaroslav $u Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic.
700    1_
$a Horváth, Csaba $u Faculty of Pharmacy, Department of Pharmacology and Toxicology, Comenius University in Bratislava, Bratislava, Slovak Republic.
700    1_
$a Kormanová, Veronika $u Faculty of Pharmacy, Department of Pharmacology and Toxicology, Comenius University in Bratislava, Bratislava, Slovak Republic.
700    1_
$a Rajtík, Tomáš $u Faculty of Pharmacy, Department of Pharmacology and Toxicology, Comenius University in Bratislava, Bratislava, Slovak Republic.
700    1_
$a Neckář, Jan $u Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic.
700    1_
$a Kolář, František $u Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic.
700    1_
$a Adameová, Adriana $u Faculty of Pharmacy, Department of Pharmacology and Toxicology, Comenius University in Bratislava, Bratislava, Slovak Republic.
773    0_
$w MED00006785 $t Journal of cellular and molecular medicine $x 1582-4934 $g Roč. 23, č. 9 (2019), s. 6429-6441
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31328381 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201125 $b ABA008
991    __
$a 20201222154034 $b ABA008
999    __
$a ok $b bmc $g 1599841 $s 1116382
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 23 $c 9 $d 6429-6441 $e 20190721 $i 1582-4934 $m Journal of cellular and molecular medicine $n J Cell Mol Med $x MED00006785
GRA    __
$a NV15-27735A $p MZ0
LZP    __
$a Pubmed-20201125

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...